CC6625
Model Information:
Cholangiocarcinoma, grade III, G2S1, with massive necrosis, and part of squamous metaplasia.IHC result: AFP(-), Hepa(-), CK7(100%++~+++), CK19(100%++~+++), CD34(vessel +), Ki-67(30%+), GP73(90%++), TG(-), P63(portion +), HCK(100%++~+++).
| Summary |
|
| Cancer Type |
Cholangiocarcinoma |
| Grade |
III |
| Stage |
NA |
| Ethnicity |
Asian |
| Gender |
F |
| Age |
63 |
| Pathology Diagnosis |
Cholangiocarcinoma, grade III, G2S1, with massive necrosis, and part of squamous metaplasia.IHC result: AFP(-), Hepa(-), CK7(100%++~+++), CK19(100%++~+++), CD34(vessel +), Ki-67(30%+), GP73(90%++), TG(-), P63(portion +), HCK(100%++~+++). |
| Biopsy Site |
Liver |
| Treatment History |
NA |
| Pathology QC |
Poorly differentiated adenocarcinoma (P4, P6) |
| Special Features |
MYC amplified |
| Mouse Strain |
Balb/c nu |
| TMA |
NA |
| Viral Status in PDX |
NA |
| Available In |
CB_CN |
| RNA Seq |
P8 |
| Exome Seq |
NA |
Growth Characteristics
Additional Characteristics
